In a study performed with a murine model of hepatocellular carcinoma, treatment with a CSF1R inhibitor resulted in increased CD8 infiltration accompanied by a reduction in MDSCs, a profile similar to what we observed in our study with the MC38 CSF1 knockout model [47]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.